FUSO PHARMACEUTICAL INDUSTRIES LTD has a total of 37 patent applications. It decreased the IP activity by 25.0%. Its first patent ever was published in 2001. It filed its patents most often in Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ONCOTHERAPY SCIENCE LTD, INST NAT SANTE RECH MED and US GOV HEALTH & HUMAN SERV.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 37 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Environmental technology | |
#5 | Organic fine chemistry | |
#6 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Suzuki Yasuhiko | 8 |
#2 | Yamasaki Shinji | 5 |
#3 | Konnai Satoru | 5 |
#4 | Okagawa Tomohiro | 5 |
#5 | Murata Shiro | 5 |
#6 | Ohashi Kazuhiko | 5 |
#7 | Asakura Masahiro | 5 |
#8 | Yamamoto Keiichi | 5 |
#9 | Nishimori Asami | 5 |
#10 | Nakajima Chie | 5 |
Publication | Filing date | Title |
---|---|---|
AU2018297856A1 | Therapeutic drug for lipid-peroxidation-induced diseases and screening method for therapeutic drugs for lipid-peroxidation-induced diseases | |
AU2018242880A1 | Anti-PD-L1 antibody for detecting PD-L1 | |
AU2017338353A1 | Inspection method enabling specific diagnosis of pathological state of diabetic nephropathy at early stage | |
AU2017313496A1 | Anti-LAG-3 antibody | |
AU2017313495A1 | Anti-PD-1 antibody | |
AU2013268382A1 | Method for producing disinfected liver | |
AU2012200573A1 | "Process for production of protein having triple-helical structure" | |
AU2006231795A1 | Process for production of protein having triple-helical structure | |
AU2001267835B2 | Cardiac arrest fluid |